The most common clinical manifestations of bladder cancer

Written by Zhou Zi Hua
Oncology
Updated on September 07, 2024
00:00
00:00

The most common clinical manifestations of bladder cancer include: one initial clinical presentation is hematuria, which typically appears as painless, intermittent gross hematuria, sometimes it can also manifest as microscopic hematuria. The hematuria may occur only once or last from one day to several days, and it can subside or stop on its own. The color of the hematuria can be light red, possibly dark brown, generally dark red. The amount of bleeding and the duration of the hematuria are not necessarily proportional to the malignancy degree, size, scope, and number of the tumor. Additionally, bladder cancer patients can experience symptoms of bladder irritation, such as frequent urination, urgent urination, painful urination, and difficulties in urination, etc.

Other Voices

doctor image
home-news-image
Written by Guan Hai Fang
Urology
1min 6sec home-news-image

How is bladder cancer diagnosed?

Firstly, imaging examinations such as ultrasound can be conducted, which if reveal tumors larger than 0.5 cm can serve as an initial screening for patients; IVU (Intravenous Urography) can show larger tumors as filling defects. Cystoscopy can also be performed by inserting a cystoscope to directly examine the bladder's shape, size, etc. If it appears round, with clear boundaries and without erosion, it is generally benign; if it has a cauliflower-like or seaweed-like appearance, it is generally malignant bladder cancer. Urine tests can also be conducted; cells from tumors found in fresh urine can lead to cytological examination of urine as an initial screening. Additionally, if conditions permit, a physical examination including a bimanual examination of the bladder can be done to preliminarily assess the tumor's size, the extent of invasion, depth, and its relationship with the pelvic wall.

doctor image
home-news-image
Written by Xu Chun Hua
Urology
39sec home-news-image

Early symptoms of bladder cancer

Hematuria is the most common and earliest symptom of bladder cancer, with 85% of patients experiencing intermittent gross hematuria which can decrease or stop on its own, often giving patients a false impression of improvement or cure, thus delaying treatment. Sometimes, hematuria is also found under a microscope, and the amount of bleeding is not necessarily consistent with the size, number, or malignancy of the tumor. The hematuria from bladder tumors can initially be mild, and other symptoms such as frequent urination, urgency, and painful urination may also occur; these are all manifestations of bladder tumors.

doctor image
home-news-image
Written by Liu Liang
Oncology
30sec home-news-image

What medicine is infused into the bladder for bladder cancer?

Postoperative intravesical chemotherapy infusion is very common in the treatment of bladder cancer. Common drugs used for infusion chemotherapy include mitomycin and anthracyclines such as epirubicin or pirarubicin. Gemcitabine is also frequently used for this purpose. The related side effects generally include irritation symptoms of the bladder, although some patients may experience relatively mild side effects.

doctor image
home-news-image
Written by Liu Liang
Oncology
1min 7sec home-news-image

Does bladder cancer require the removal of the bladder?

Whether or not to remove the entire bladder in cases of bladder cancer depends on whether the tumor has invaded the base layer and whether there is distant metastasis. For non-muscle invasive bladder cancer, where the muscle layer is not invaded and there is no distant metastasis, typically found in stage 0 and stage 1 bladder cancer patients, there is no need for complete removal of the bladder. The standard treatment in such cases generally involves transurethral resection of the bladder tumor. If the tumor has invaded the base layer but there is no distant metastasis, termed muscle-invasive bladder cancer, patients in this category require radical cystectomy, which involves the removal of the entire bladder. If there is distant metastasis, termed metastatic bladder cancer, surgical treatment is not pursued; instead, palliative chemotherapy is the primary approach.

doctor image
home-news-image
Written by Wang Jian
Urology
52sec home-news-image

Is bladder cancer scary?

Bladder cancer is the most common malignant tumor in urological surgery, primarily occurring in the bladder mucosa. Its symptoms include painless, intermittent gross hematuria, with nearly 100% of patients experiencing blood in the urine. The presence of hematuria should highly raise the suspicion of bladder cancer, and the examinations mainly include routine urinalysis and an ultrasound of the urinary system. Bladder cancer is not to be feared if it is detected and treated early. The surgery can be relatively simple, and minimally invasive treatment through the urethra, such as plasma electrosection or laser excision, is possible. Since bladder cancer can recur, postoperative management should include bladder perfusion therapy and regular cystoscopy re-examinations. Thus, bladder cancer is not to be feared, as early detection and treatment can lead to a cure.